These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3261818)

  • 1. Cimetidine reduces cyclosporine inhibition of interleukin-2 production.
    Gifford RR; Tilberg AF
    J Surg Res; 1988 Sep; 45(3):276-80. PubMed ID: 3261818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histamine type-2 receptor antagonist immune modulation. II. Cimetidine and ranitidine increase interleukin-2 production.
    Gifford RR; Tilberg AF
    Surgery; 1987 Aug; 102(2):242-7. PubMed ID: 3497460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The in vivo immunosuppressive action of suppressor cells from alloantigen-cyclosporine-treated mice and the capacity of spleen cells to release interleukins and gamma-interferon.
    Yoshimura N; Matsui S; Hamashima T; Kita M; Oka T
    Transplantation; 1988 Jan; 45(1):157-62. PubMed ID: 2962348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of interleukin 2 on the immunosuppressive action of cyclosporine.
    Hess AD
    Transplantation; 1985 Jan; 39(1):62-8. PubMed ID: 3155579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporine therapy of rat heart allograft recipients and release of interleukins (IL 1, IL 2, IL 3): a role for IL 3 in graft tolerance?
    Abbud-Filho M; Kupiec-Weglinski JW; Araujo JL; Heidecke CD; Tilney NL; Strom TB
    J Immunol; 1984 Nov; 133(5):2582-6. PubMed ID: 6237152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histamine type-2 receptor antagonist immune modulation. I. Increased cell-mediated cytotoxicity in normal and in down-regulated systems.
    Gifford RR; Voss BV; Schmidtke JR; Ferguson RM
    Surgery; 1988 Feb; 103(2):184-92. PubMed ID: 2963399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of cyclosporins A and G on functional activation of a T-helper-lymphocyte line mediating experimental autoimmune uveoretinitis.
    Caspi RR; McAllister CG; Gery I; Nussenblatt RB
    Cell Immunol; 1988 May; 113(2):350-60. PubMed ID: 2965988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of the CD28 activation pathway on the immunosuppressive action of cyclosporine.
    Hess AD; Bright EC
    Transplantation; 1991 Jun; 51(6):1232-40. PubMed ID: 1646506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of H2-receptor antagonists on renal function in cyclosporine-treated renal transplant patients.
    Pachon J; Lorber MI; Bia MJ
    Transplantation; 1989 Feb; 47(2):254-9. PubMed ID: 2645708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of histamine type II receptors on CD8+ T cells by interleukin-2 and cimetidine.
    Shibata M; Hoon D; Okun E; Morton D
    Int Arch Allergy Immunol; 1992; 97(1):8-16. PubMed ID: 1533853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo evaluation of the effects of altered cyclosporine metabolism on its immunosuppressive potency.
    Babany G; Morris RE; Babany I; Shepherd S; Kates RE
    J Pharmacol Exp Ther; 1989 Mar; 248(3):893-9. PubMed ID: 2649657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamic assessment of the in vivo cyclosporine effect on interleukin-2 production by lymphocytes in kidney transplant recipients.
    Yoshimura N; Kahan BD
    Transplantation; 1985 Dec; 40(6):661-6. PubMed ID: 3934806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppressor and cytolytic cell function in multiple sclerosis. Effects of cyclosporine A and interleukin 2.
    Bania MB; Antel JP; Reder AT; Nicholas MK; Arnason BG
    J Clin Invest; 1986 Aug; 78(2):582-6. PubMed ID: 2942563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blocking of interleukin-2 production, but not the tissue destruction induced by cytotoxic T cells, by cyclosporine.
    Noble RL; Steinmuller D
    Transplantation; 1989 Feb; 47(2):322-6. PubMed ID: 2784016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of mitogen-induced lymphocyte proliferation by ouabain: interference with interleukin 2 production and interleukin 2 action.
    Stoeck M; Northoff H; Resch K
    J Immunol; 1983 Sep; 131(3):1433-7. PubMed ID: 6604100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic benefits of calcium channel blockers in cyclosporine-treated organ transplant recipients: blood pressure control and immunosuppression.
    Weir MR
    Am J Med; 1991 May; 90(5A):32S-36S. PubMed ID: 2039018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro immunosuppressive properties of cyclosporine metabolites.
    Freed BM; Rosano TG; Lempert N
    Transplantation; 1987 Jan; 43(1):123-7. PubMed ID: 2948307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A critical time window for the analgesic effect of central histamine in the partial sciatic ligation model of neuropathic pain.
    Yu J; Tang YY; Wang RR; Lou GD; Hu TT; Hou WW; Yue JX; Ohtsu H; Shi LY; Zhang SH; Chen Z
    J Neuroinflammation; 2016 Jun; 13(1):163. PubMed ID: 27342775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of TC-1 cytokine production, effector cytotoxic T lymphocyte development and alloantibody production by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Kerkvliet NI; Baecher-Steppan L; Shepherd DM; Oughton JA; Vorderstrasse BA; DeKrey GK
    J Immunol; 1996 Sep; 157(6):2310-9. PubMed ID: 8805628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paradoxical effects of cyclosporine on concanavalin A-induced blastogenesis.
    Shabtai M; Waltzer WC; Frischer Z; Bartkus JM; Gonder MJ
    J Urol; 1991 Jan; 145(1):17-9. PubMed ID: 1984085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.